Single-cell analysis reveals distinct immune characteristics of hepatocellular carcinoma in HBV-positive vs. HBV-negative cases

Guardado en:
Bibliografiske detaljer
Udgivet i:Molecular and Clinical Oncology vol. 23, no. 3 (2025)
Hovedforfatter: Liu, Ke
Andre forfattere: Chen, Erbao, Liang, Jiaming, Li, Yanyan, Cheng, Binghua, Shi, Wenli, Zhou, Zeyu, Zhou, Wenjie, Tian, Hui, Shao, Ximing
Udgivet:
Spandidos Publications UK Ltd.
Fag:
Online adgang:Citation/Abstract
Full Text
Full Text - PDF
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

MARC

LEADER 00000nab a2200000uu 4500
001 3234838490
003 UK-CbPIL
022 |a 2049-9450 
022 |a 2049-9469 
024 7 |a 10.3892/mco.2025.2871  |2 doi 
035 |a 3234838490 
045 2 |b d20250101  |b d20251231 
100 1 |a Liu, Ke 
245 1 |a Single-cell analysis reveals distinct immune characteristics of hepatocellular carcinoma in HBV-positive vs. HBV-negative cases 
260 |b Spandidos Publications UK Ltd.  |c 2025 
513 |a Journal Article 
520 3 |a Infection with the hepatitis B virus (HBV) is a key risk factor for hepatocellular carcinoma (HCC) development and progression. It is widely recognized that immunopathological mechanisms are pivotal in the development of HBV-associated HCC; nevertheless, the specific underlying mechanisms through which HBV-induced modifications within the tumor microenvironment (TME) contribute to HCC pathogenesis have yet to be fully elucidated. In the present study, single-cell RNA sequencing was utilized to analyze and compare the immune landscapes between HBV-positive and HBV-negative HCC. These experiments revealed that HBV infection significantly modifies the composition and state of immune cells, leading to the suppression and exhaustion of T cells within the TME. Specifically, increases in the proportions of SLC4A10+ CD8+ T cells and IFITM3+ macrophages were observed, along with an upregulation of the gene SLC35F1 in various immune cell subtypes. Taken together, these findings have offered valuable insights into the alteration of the immunological microenvironment in HCC that is associated with HBV infection, suggesting possible targets for immunotherapeutic intervention. 
610 4 |a Peking University 
653 |a Infections 
653 |a Patients 
653 |a Software 
653 |a Cells 
653 |a Gene expression 
653 |a Immune system 
653 |a Lymphocytes 
653 |a Genomes 
653 |a Liver cancer 
653 |a Genomics 
653 |a Tumors 
653 |a Viral infections 
653 |a Survival analysis 
653 |a Mann-Whitney U test 
653 |a Hepatitis B 
700 1 |a Chen, Erbao 
700 1 |a Liang, Jiaming 
700 1 |a Li, Yanyan 
700 1 |a Cheng, Binghua 
700 1 |a Shi, Wenli 
700 1 |a Zhou, Zeyu 
700 1 |a Zhou, Wenjie 
700 1 |a Tian, Hui 
700 1 |a Shao, Ximing 
773 0 |t Molecular and Clinical Oncology  |g vol. 23, no. 3 (2025) 
786 0 |d ProQuest  |t Health & Medical Collection 
856 4 1 |3 Citation/Abstract  |u https://www.proquest.com/docview/3234838490/abstract/embedded/7BTGNMKEMPT1V9Z2?source=fedsrch 
856 4 0 |3 Full Text  |u https://www.proquest.com/docview/3234838490/fulltext/embedded/7BTGNMKEMPT1V9Z2?source=fedsrch 
856 4 0 |3 Full Text - PDF  |u https://www.proquest.com/docview/3234838490/fulltextPDF/embedded/7BTGNMKEMPT1V9Z2?source=fedsrch